Language Passa all'italiano
Home
Company
Who we are Mission & Vision Ethical code Join us Certifications and Quality
Services and Products
Products VR and Simulation Engineering & System Integration Research and Development
Markets News Contacts
Discover the products
Header image

Alessio Calabrò on AI news at the Artificial Intelligence in Medicine Conference

April 9 - 2025

On April 3, a major event dedicated to the impact of Artificial Intelligence (AI) on professions and strategic sectors, including medicine, was held at Legance’s Milan office. Among the day’s protagonists was Alessio Calabrò, CEO of RAIT88, who brought the company’s contribution on the topic of digital transformation in healthcare.

The event, organized by Legance and dedicated to the analysis of the new European AI Act, focused on the concept of “responsible” artificial intelligence, combining innovation, security and social impact. It was a multidisciplinary discussion involving legal, medical, technical and business experts, highlighting how AI is changing the way we live, work and care.

RAIT88’s talk: training and safety in augmented healthcare

In his speech, Alessio Calabrò shared RAIT88’s concrete experience in using artificial intelligence and augmented reality to train technical staff. In fact, the company has developed solutions that use immersive environments and virtual simulations to reproduce real operational scenarios, improving learning and reducing error margins.

A significant example is the augmented reality system for avionics maintenance, which was also presented at the PBExpo 2025 international exhibition and is now being adapted for applications in other areas as well. The goal is to offer advanced training tools for physicians, nurses and technicians as well, reducing the use of paper-based materials and encouraging a “hands-on” approach even at a distance.

AI Act and medicine: an alliance to be built with awareness

In the context of the meeting, the need for a regulatory framework to ensure ethics and transparency in artificial intelligence systems, especially in critical areas such as medicine, became clear. The AI Act, currently being implemented in Europe, defines risk levels and criteria for the use of AI, with a focus on “high-risk” sectors such as healthcare.

RAIT88’s position, reiterated by Calabrò, is clear: technology can and should support healthcare professionals, but without replacing their decision-making role. AI must be a tool to support care, capable of analyzing large volumes of clinical data, improving diagnoses and optimizing therapeutic paths, but always under the supervision of the human being.

Future challenges: integration, training and governance

During the discussion, it was emphasized that the challenge is not only technological, but also organizational and cultural. Healthcare facilities must be ready for AI solutions by investing in staff training and adequate infrastructure. At the same time, clear rules need to be established on the management of sensitive data, interoperability of systems, and liability in case of algorithmic error.

In this scenario, RAIT88 stands as a technological and strategic partner for hospital companies, public and private entities that want to adopt innovative tools in a safe, sustainable and regulatory-compliant manner.

Conclusion: medicine and artificial intelligence, a combination already present

The message of the event is clear: medicine and artificial intelligence are not a distant future, but a reality already in place. RAIT88, with its integrated approach between technology, education and compliance, is ready to play a leading role in this change.

The application of AI in medicine is not limited to diagnostics or clinical data management: it is a revolution that also affects the processes, decision-making flows, training, and safety of practitioners. RAIT88 will continue to invest in research and development to ensure that innovation always serves people and collective well-being.